The largest database of trusted experimental protocols

Nod cb17 prkdcscid j

Manufactured by Jackson ImmunoResearch
Sourced in United States, Montenegro

NOD.CB17-Prkdcscid/J is a laboratory mouse strain that is widely used in immunology research. This strain is characterized by a severe combined immunodeficiency (SCID) mutation, which results in the absence of functional T and B cells. This mouse strain is often used as a model for the study of human immune responses and the development of new immunotherapies.

Automatically generated - may contain errors

53 protocols using nod cb17 prkdcscid j

1

Subcutaneous Neuroblastoma Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 5 × 106 neuroblastoma cells in 200 µl serum-free DMEM were injected subcutaneously into flanks of 6-week-old female NOD.SCID/NCr mice (NOD.CB17-Prkdcscid/J, stock number 001303, Jackson Laboratory, Bar Harbor, ME). Approximately 4 weeks after injection, tumors were removed and weighed. All animal experiments were pre-approved by the Institutional Animal Care and Use Committee of Medical College of Georgia, Augusta University.
+ Open protocol
+ Expand
2

Xenograft Tumor Implantation in NOD-scid Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five to six week old Nod-scid (NOD.CB17-Prkdcscid/J) and NOD-scid gamma (NOD-scid IL2Rgnull) mice were obtained from the Jackson Laboratories. 107 tumor cells were injected into the flanks in 0.9% sterile saline. Tumor and body weight was measured twice weekly. All studies beyond primary tumors (Figures 1A) were on tumors reimplanted once and cell lines derived therefrom. All animal studies were SBP ACUC approved
+ Open protocol
+ Expand
3

Immunodeficient Mice for Tumor Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunodeficient female non-obese diabetic/severe combined immunodeficiency (NOD-SCID) mice, 8–12 weeks old, were purchased from The Jackson Laboratory (NOD.CB17-Prkdcscid/J; stock # 001303; Bar Harbor, ME). Mice were injected on day 0 with 2F7 cells (106) by intra-peritoneal (i.p) injection as described 17 (link). Mice were treated by i.p. injection with 200 μg of ch128.1, 200 μg of isotype control (IgG3), or buffer alone [Hank’s balanced salt solution (HBSS)] on days 1, 8, and 22. Animals were monitored for tumor development and euthanized when moribund or when the abdomen was distended. Survival was recorded as the number of days from tumor challenge to euthanasia. Survival plots were generated and statistical analysis (log-rank test) was performed using GraphPad Prism Version 5 (GraphPad Software, Inc., La Jolla, CA).
+ Open protocol
+ Expand
4

In Vivo Expansion of Primary ALL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary ALL cells were thawed, washed with PBS and 1x107 cells were injected via the tail vein in unconditioned NOD/SCID (NOD.CB17-Prkdcscid/J) mice (The Jackson Laboratory, Bar Harbor, ME) for an in vivo expansion step. Successfully engrafted mice were sacrificed, ALL cells were collected from spleen, liver and bone marrow and 1x107 fresh cells were immediately injected in a higher number of secondary recipient mice for the experiments. In case of ALL cell lines, mice for the experiments were injected with cells expanded in vitro.
+ Open protocol
+ Expand
5

Murine Models for Autoimmune Diabetes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male and female NOD/ShiLtJ (NOD), NOD.CB17-Prkdcscid/J (NOD-SCID), NOD.129S6(B6)-CD4tm1knw/DvsJ (CD4null), and Balb/cJ mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Male and female NOD.129S2(B6)-CD8atm1Mak/DvsJ (CD8null) mice were kindly provided by David Serreze (The Jackson Laboratory). NOD mice expressing the bicistronic Foxp3-green fluorescent protein (GFP) (NOD), obtained by backcrossing the Foxp3-GFP knock-in C57BL/6J mice56 (link) for > 20 generations onto the NOD background, were a kind gift from Vijay Kuchroo (Harvard University). For transfer studies, donor mice were 5–6 weeks old and recipients were 7–9 weeks old. For ex vivo analyses, mice were 12–17 weeks old. The exact sample size (n) and biological and experimental replicates are indicated in each figure legend. Samples sizes were determined based on previous transfer studies and typically included 10–15 mice per group pooled from multiple experiments. All mice were monitored for the presence of glucosuria using Diastix urine dipsticks (Bayer Diagnostics, Whippany, NJ). A positive test was indicative of autoimmune diabetes development. Mice were maintained and used in accordance with the University of Iowa Institutional Animal Care and Use Committee Guidelines.
+ Open protocol
+ Expand
6

In Vivo Macrophage Tracking via CDNP-VT680

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal research was conducted in compliance with the Institutional Animal Care and Use Committees at Massachusetts General Hospital (MGH). Unless otherwise stated, experiments were performed using female C57BL/6 that were 6- to 8-weeks old at the start of the experiment, and animals were sourced from The Jackson Laboratory. Intravital examination of CDNP-VT680 distribution into macrophages was examined in recently developed NOD MerTKGFP/+ mice45 , crossed into NOD SCID mice (NOD.CB17-Prkdcscid/J; #001303, Jackson). Intravital examination of IL12 expression was performed using p40-IRES-eYFP IL12 reporter mice (#015864, Jackson) described previously70 (link).
+ Open protocol
+ Expand
7

Murine Models for Immunology Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
All studies were performed under approved protocols by the University of Miami’s Institutional Animal Care and Use Committee (IACUC). Mouse strains purchased from the Jackson Laboratory (Bar Harbor, ME, USA) included NOD/ShiLtJ (stock number 001976; NOD), NOD.CB17-Prkdcscid/J (stock number 001303; NOD.scid), B6.129S7-Rag1tm1Mom/J (stock number 002216; B6/Rag1), NOD.129S7(B6)-Rag1tm1Mom/J (stock number 003729; NOD.Rag−/−) C57BL/6J (stock number 000664; B6) and DBA/2J (stock number 000671). NOD.Gfp mouse founders were kindly provided by R. M. Tisch (Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA) [20 (link)]. Mice were housed during the studies in micro-isolated cages in virus antibody-free rooms with free access to autoclaved/irradiated food and water under the supervision of the University of Miami’s Department of Veterinary Resources (DVR).
+ Open protocol
+ Expand
8

Tumor Growth Inhibition in NSG Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments were approved by the local authorities. NOD.Cg-PrkdcscidI12rgtm1Wjl/SzJ (NSG) or NOD.CB17-Prkdcscid/J (non-obese diabetic/severe combined immunodeficiency [NOD/SCID]) mice (Jackson Laboratory, USA) were used at 6–8 weeks of age. Fluorescence-activated cell sorting (FACS)-sorted SW480 cells (CD133high, CD133+, CD133) were resuspended 1:1 in Matrigel (BD, Germany) and serum-free medium, and were injected subcutaneously into the flank at 5 × 104 cells per mouse. For the in vivo treatment, MK-2206 (100 mg/kg) was administered orally three times a week when tumor size reached 0.2–0.3 cm in diameter. Tumor growth was measured twice weekly using a caliper, and mice were sacrificed when tumor size reached a diameter of 1 cm.
+ Open protocol
+ Expand
9

NOD Mouse Strains for Immunology

Check if the same lab product or an alternative is used in the 5 most similar protocols
NOD CD45.2 congenic (NOD.B6-Ptprcb/6908MrkJacJ) and NOD.SCID (NOD.CB17-PrkdcSCID/J) mice were purchased from Jackson Laboratories. NOD-Y3 IL-2Rβ+/+, NOD-Y3 IL-2Rβ +/−, NOD-Y3 IL-2Rβ−/− mice, where Y3 refers to the mutant IL-2Rβ transgene, were developed by backcrossing C57BL/6-Y3 IL-2Rβ−/− mice (32 (link)) to NOD/ShiLtJ mice for 12 generations. All Idd loci were confirmed to be of NOD origin. NOD/Foxp3-RFP reporter (FIR) mice were previously described (64 (link)) and crossed to NOD BDC2.5 and NOD-Y3 IL-2Rβ +/+ mice to yield NOD-Y3-FIR, NOD BDC2.5-FIR, and NOD-Y3 BDC2.5-FIR mice. All mice were housed in a specific pathogen-free animal facility at the University of Miami. The Institutional Animal Care and Use Committee at the University of Miami reviewed and approved all animal studies conducted in this study.
+ Open protocol
+ Expand
10

NOD-Scid Mice for Glucose Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunodeficient NOD-Scid (NOD.CB17-Prkdcscid/J) female mice were purchased from The Jackson Laboratory (Cat No. 001303) and used for experiments at 8 weeks of age. Random blood glucose levels were measured from tail vein blood using the Breeze2 glucometer (Bayer AG, Leverkusen, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!